Gene engineering tool provider Inscripta has grown its series C round to almost $106m, securing the extra capital from existing backers such as Mérieux Développement.

The radiography image analysis platform developer has completed a series B round that was led by new distribution partner Marubeni.

Unilever Ventures returned to participate in an L Catterton-led series B round that will fund the hair supplement developer's marketing and research and development activities.

Sinopharm Capital helped supply funding to orthopaedic-focused device maker Suzhou and Science Technology Development, with the latter eyeing new products in areas including sports medicine.

The pet food and care provider has formed an open innovation subsidiary, Kinship, which will oversee a $100m strategic investment fund.

Lundbeckfonden Ventures co-led ocular cancer therapy developer Aura's series D round, which also featured Chiesi Ventures.

The Oxford University genetic sequencing spinout is reportedly mulling an IPO that would provide exits to investors including commercialisation firm IP Group.

The industry-academia partnership will start out with collaborations in the healthcare, robotics and human resources spaces, including a sports science tie-up with a Rakuten-owned baseball team and plans for software development hackathons.

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

Varian led a round for the targeted cancer drug developer that included fellow existing investors including Johnson & Johnson and Pivotal BioVenture Partners.